FI107149B - Menetelmä (E)-N,N-dietyyli-2-syano-3-(3,4-dihydroksi-5-nitro-fenyyli)akryyliamidin stabiilin polymorfisen muodon valmistamiseksi - Google Patents
Menetelmä (E)-N,N-dietyyli-2-syano-3-(3,4-dihydroksi-5-nitro-fenyyli)akryyliamidin stabiilin polymorfisen muodon valmistamiseksi Download PDFInfo
- Publication number
- FI107149B FI107149B FI905198A FI905198A FI107149B FI 107149 B FI107149 B FI 107149B FI 905198 A FI905198 A FI 905198A FI 905198 A FI905198 A FI 905198A FI 107149 B FI107149 B FI 107149B
- Authority
- FI
- Finland
- Prior art keywords
- dihydroxy
- acrylamide
- cyano
- diethyl
- polymorphic form
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/41—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by carboxyl groups, other than cyano groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8924838A GB2238047B (en) | 1989-11-03 | 1989-11-03 | Stable polymorphic form of (e)-n,n-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide and the process for its preparation |
GB8924838 | 1989-11-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
FI905198A0 FI905198A0 (fi) | 1990-10-23 |
FI107149B true FI107149B (fi) | 2001-06-15 |
Family
ID=10665678
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI905198A FI107149B (fi) | 1989-11-03 | 1990-10-23 | Menetelmä (E)-N,N-dietyyli-2-syano-3-(3,4-dihydroksi-5-nitro-fenyyli)akryyliamidin stabiilin polymorfisen muodon valmistamiseksi |
Country Status (13)
Country | Link |
---|---|
US (1) | US5135950A (fr) |
EP (1) | EP0426468B1 (fr) |
JP (1) | JP2823680B2 (fr) |
AT (1) | ATE127447T1 (fr) |
BR (1) | BR1100289A (fr) |
DE (2) | DE69022166T2 (fr) |
DK (1) | DK0426468T3 (fr) |
ES (1) | ES2075885T3 (fr) |
FI (1) | FI107149B (fr) |
GB (1) | GB2238047B (fr) |
GR (1) | GR3017526T3 (fr) |
LU (1) | LU91071I2 (fr) |
NL (1) | NL300147I1 (fr) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5283352A (en) * | 1986-11-28 | 1994-02-01 | Orion-Yhtyma Oy | Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same |
GB9113431D0 (en) * | 1991-06-20 | 1991-08-07 | Orion Yhytma Oy | Method for the preparation of 3,4-dihydroxy-5-nitrobenzaldehyde |
CA2080554A1 (fr) * | 1991-10-15 | 1993-04-16 | Mitsubishi Chemical Corporation | Derives du styrene |
JPH05301838A (ja) * | 1991-10-15 | 1993-11-16 | Mitsubishi Kasei Corp | スチレン誘導体 |
US20060013875A1 (en) * | 2002-05-29 | 2006-01-19 | Impax Laboratories, Inc. | Combination immediate release controlled release levodopa/carbidopa dosage forms |
US7094427B2 (en) * | 2002-05-29 | 2006-08-22 | Impax Laboratories, Inc. | Combination immediate release controlled release levodopa/carbidopa dosage forms |
BRPI0417799A (pt) * | 2003-12-19 | 2007-04-17 | Hoffmann La Roche | inibidores de comt |
AU2003296838A1 (en) * | 2003-12-24 | 2005-08-11 | Siddiqui Mohammed Jaweed Mukarram | An efficient process for the manufacture of (e)-entacapone polymorphic form a |
WO2005066117A1 (fr) * | 2003-12-29 | 2005-07-21 | Wockhardt Limited | Polymorphes stables de (e)-n,n-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide |
AU2003287844A1 (en) * | 2003-12-31 | 2005-07-21 | Cilag Ag | Novel crystalline forms of entacapone, and production thereof |
US20080076825A1 (en) * | 2003-12-31 | 2008-03-27 | Thomas Bader | Novel Crystalline Forms of Entacapone and Production Thereof |
EP1577289A1 (fr) | 2004-03-18 | 2005-09-21 | Revotar Biopharmaceuticals AG | Inhibiteurs de selectine a petites molecules non glycosylees/glycosidiques/peptidiques pour le traitement de troubles inflammatoires |
AU2005257982B8 (en) * | 2004-06-16 | 2011-03-10 | Jack Arbiser | Carbazole formulations for the treatment of psoriasis and angiogenesis |
EP1812070B1 (fr) | 2004-11-10 | 2013-10-02 | Orion Corporation | Traitement du syndrome des jambes sans repos |
EA013161B1 (ru) | 2005-06-08 | 2010-02-26 | Орион Корпорейшн | Дозированная форма для перорального применения |
AU2006261893A1 (en) * | 2005-06-23 | 2007-01-04 | Combinatorx, Incorporated | Improved dosage forms for movement disorder treatment |
EP1764093A1 (fr) | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Nouveaux composés aromatiques et leur application médical |
EP1764095A1 (fr) | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Nouveaux derivés de nitrocatéchol ayant activité de ligande de selectine |
EP1764096A1 (fr) | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Nouveaux derivés de phloroglucinol ayant activité de ligande de selectine |
EP1945607B1 (fr) * | 2005-11-09 | 2009-10-14 | USV Limited | Procédé pour la préparation de (e)-n,n-diéthyl-2-cyano-3-(3,4-dihydroxy-5-nitrophényl)acrylamide (entacapone) extrêmement pur |
US20080300420A1 (en) * | 2006-01-02 | 2008-12-04 | Sanmar Speciality Chemicals Ltd. | Process for the Preparation of Entacapone Form-A |
US7932415B2 (en) * | 2006-02-06 | 2011-04-26 | Orion Corporation | Process for manufacturing entacapone |
WO2007094007A1 (fr) * | 2006-02-13 | 2007-08-23 | Suven Life Sciences Ltd., | Procede ameliore de preparation de l'entacapone |
WO2007113845A1 (fr) * | 2006-04-03 | 2007-10-11 | Alembic Limited | Procédé de préparation de (e)-2-cyano-3-(3, 4-dihydroxy-5-nitrophényl)-n, n-diéthyl-2-propénamide (entacapone) |
GB0610207D0 (en) * | 2006-05-23 | 2006-07-05 | Pliva Istrazivanje I Razvoj D | New forms of active pharmaceutical ingredient |
US20080131492A1 (en) * | 2006-06-23 | 2008-06-05 | Spherics, Inc. | Dosage forms for movement disorder treatment |
US20080004343A1 (en) * | 2006-06-29 | 2008-01-03 | Wockhardt Limited | Stable polymorphs of (E)-N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide |
GB0613826D0 (en) * | 2006-07-12 | 2006-08-23 | Pliva Istrazivanje I Razvoj D | Process and product |
ES2306587B1 (es) * | 2006-11-15 | 2009-08-07 | Quimica Sintetica, S.A. | Nueva forma cristalina de entacapona y procedimiento para su obtencion. |
ITMI20062450A1 (it) * | 2006-12-19 | 2008-06-20 | Dipharma Spa | Procedimento per la preparazione di entacapone |
EP2063867A2 (fr) * | 2006-12-22 | 2009-06-03 | Combinatorx, Incorporated | Compositions pharmaceutiques pour le traitement de la maladie de parkinson et de troubles apparentés |
ES2319024B1 (es) * | 2007-02-13 | 2009-12-11 | Quimica Sintetica, S.A. | Procedimiento para la obtencion de entacapona sustancialmente libre de isomero z, sus intermedios de sintesis y nueva forma cristalina. |
WO2009084031A2 (fr) * | 2007-12-03 | 2009-07-09 | Neuland Laboratories Ltd | Procédé amélioré de préparation de la forme polymorphe a du (2e)-2-cyano-3-(3,4-dihydroxy-5-nitrophényl)-n,n-diéthyl-2-propènamide |
EP2251323B1 (fr) | 2009-05-14 | 2014-04-23 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Procédé de purification d'entacapone |
EA026419B1 (ru) | 2010-03-04 | 2017-04-28 | Орион Корпорейшн | Применение леводопы, карбидопы и энтакапона для лечения болезни паркинсона |
CN103845317B (zh) | 2012-11-28 | 2018-05-08 | 北京生命科学研究所 | 恩他卡朋在预防或治疗肥胖等代谢综合征中的应用 |
US10987313B2 (en) | 2013-10-07 | 2021-04-27 | Impax Laboratories, Llc | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof |
CA2926082C (fr) | 2013-10-07 | 2022-06-14 | Impax Laboratories, Inc. | Formulations mucoadhesives a liberation controlee de levodopa et/ou d'esters de levodopa et leurs utilisations |
CN104402764A (zh) * | 2014-11-26 | 2015-03-11 | 千辉药业(安徽)有限责任公司 | 一种恩他卡朋的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
YU213587A (en) * | 1986-11-28 | 1989-06-30 | Orion Yhtymae Oy | Process for obtaining new pharmacologic active cateholic derivatives |
EP0304493B1 (fr) * | 1987-03-11 | 1992-09-02 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Derives d'hydroxystyrene |
AU618595B2 (en) * | 1988-04-28 | 1992-01-02 | Suntory Limited | Derivative of caffeic acid and pharmaceutical composition containing the same |
JP2535058B2 (ja) * | 1988-07-29 | 1996-09-18 | 富士通株式会社 | 半導体装置の製造方法 |
-
1989
- 1989-11-03 GB GB8924838A patent/GB2238047B/en not_active Revoked
-
1990
- 1990-10-23 FI FI905198A patent/FI107149B/fi not_active IP Right Cessation
- 1990-10-31 US US07/606,717 patent/US5135950A/en not_active Expired - Lifetime
- 1990-11-01 AT AT90311963T patent/ATE127447T1/de active
- 1990-11-01 DE DE69022166T patent/DE69022166T2/de not_active Expired - Lifetime
- 1990-11-01 ES ES90311963T patent/ES2075885T3/es not_active Expired - Lifetime
- 1990-11-01 DK DK90311963.4T patent/DK0426468T3/da active
- 1990-11-01 EP EP90311963A patent/EP0426468B1/fr not_active Expired - Lifetime
- 1990-11-01 DE DE200412000014 patent/DE122004000014I1/de active Pending
- 1990-11-02 JP JP2298708A patent/JP2823680B2/ja not_active Expired - Lifetime
-
1995
- 1995-09-26 GR GR950402644T patent/GR3017526T3/el unknown
-
1997
- 1997-04-15 BR BR1100289-1A patent/BR1100289A/pt active IP Right Grant
-
2004
- 2004-04-09 LU LU91071C patent/LU91071I2/fr unknown
- 2004-04-16 NL NL300147C patent/NL300147I1/nl unknown
Also Published As
Publication number | Publication date |
---|---|
BR1100289A (pt) | 1999-10-05 |
US5135950A (en) | 1992-08-04 |
JP2823680B2 (ja) | 1998-11-11 |
DE69022166D1 (de) | 1995-10-12 |
GB8924838D0 (en) | 1989-12-20 |
DK0426468T3 (da) | 1995-10-23 |
ES2075885T3 (es) | 1995-10-16 |
GB2238047A (en) | 1991-05-22 |
JPH03169844A (ja) | 1991-07-23 |
ATE127447T1 (de) | 1995-09-15 |
FI905198A0 (fi) | 1990-10-23 |
DE69022166T2 (de) | 1996-02-15 |
LU91071I2 (fr) | 2005-06-21 |
DE122004000014I1 (de) | 2004-08-12 |
GR3017526T3 (en) | 1995-12-31 |
GB2238047B (en) | 1993-02-10 |
NL300147I1 (nl) | 2004-07-01 |
EP0426468B1 (fr) | 1995-09-06 |
EP0426468A3 (en) | 1992-05-06 |
EP0426468A2 (fr) | 1991-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI107149B (fi) | Menetelmä (E)-N,N-dietyyli-2-syano-3-(3,4-dihydroksi-5-nitro-fenyyli)akryyliamidin stabiilin polymorfisen muodon valmistamiseksi | |
JP4928727B2 (ja) | 脂肪酸アミドの製造方法 | |
JP5112399B2 (ja) | アゴメラチン合成の新規な方法 | |
MX2015004764A (es) | Compuestos utiles en la sintesis de compuestos de benzamida. | |
WO2006064296A1 (fr) | Procede de preparation du (e)-n1n- diethyl-2-cyano-3-(3,4-dihydroxy-t5-nitro-phenyl)-acrylamide sous une forme polymorphe stable et des intermediaires du procede | |
US20080300420A1 (en) | Process for the Preparation of Entacapone Form-A | |
JP2682705B2 (ja) | 2,6−ジクロロフェニルアミノベンゼン酢酸誘導体及びジフェニルアミン誘導体の製造方法。 | |
HU201523B (en) | Process for producing retinoyl chlorides | |
AU2003288712A1 (en) | Alternative process for the preparation of entacapone | |
AU2003292465A1 (en) | Stable polymorphs of (e)-n,n-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide | |
AU615521B2 (en) | Compounds used in the preparation of nifedipine | |
DE60021410T2 (de) | Verfahren zur herstellung von ketiminen | |
CA2327056C (fr) | Reduction par phosphine d'azides a des amides | |
KR0141482B1 (ko) | 0-카르복시피리딜-및 0-카르복시퀴놀릴이미다졸리논의 개선된 제조방법 | |
US6235935B1 (en) | Method of manufacturing high purity oximes from aqueous hydroxylamine and ketones | |
GB2061257A (en) | Method for the preparation of 2-chlorobenzoyl chloride, and its uses | |
US5631403A (en) | Process for the preparation of hydroxycarboxanilides | |
SK77894A3 (en) | Method of producing of nitriles of aminopropione acid | |
US5231215A (en) | Method of manufacturing substituted monoamides of dicarboxylic-acid monoalkyl esters | |
US4918230A (en) | Process for the preparation 4-bromoaniline hydrobromides | |
US5973205A (en) | Process for the preparation of 1, 3-diaminopropane derivatives and intermediates useful in this process | |
HU218599B (hu) | Eljárás 4-(3,4-diklór-fenil)-3,4-dihidro-1-(2H)-naftalin-1-on előállítására | |
KR820002043B1 (ko) | β-이소부티릴 아미노크로톤산 아미드의 제조방법 | |
JPS5931748A (ja) | α−シアノアクリル酸エステルの製造法 | |
CA2710598C (fr) | Synthese d'iodixanol dans l'eau |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
SPCF | Supplementary protection certificate application filed |
Spc suppl protection certif: L20020006 |
|
SPCF | Supplementary protection certificate application filed |
Spc suppl protection certif: L20040007 |
|
FG | Patent granted |
Owner name: ORION-YHTYMAE OY |
|
PC | Transfer of assignment of patent |
Owner name: ORION CORPORATION Free format text: ORION CORPORATION |
|
SPCG | Supplementary protection certificate granted |
Spc suppl protection certif: 221 Extension date: 20151023 |
|
SPCR | Lapse or expiry of a supplementary protection certificate |
Spc suppl protection certif: 221 Effective date: 20140311 |